You searched for "what is true transparency". Here are the results:
Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, House Bill 1260, Prescription Drug Price Transparency. We need your help to contact your legislator UR... Read More
Get weekly updates from Colorado’s leading source for life sciences news and information. Read More
Colorado’s 2026 legislative session, the Second Regular Session of the 75th General Assembly, concluded on May 13, the 120th day of session. Of the 626 bills introduced by the General Assembly, Colorado BioScience Association (CBSA) took positions on 23 bills aligned to CBSA’s Policy Priorities, re... Read More
This week’s policy blog includes federal and state updates on topics relevant to Colorado’s life sciences ecosystem: Reauthorization of SBIR/STTR Programs Colorado’s Budget Shortfall and Special Legislative Session Colorado PDAB’s Third Upper Payment Limit Rulemaking Hearing for En... Read More
On July 11, the Colorado Prescription Drug Affordability Board (PDAB or Board) held its second upper payment limit (UPL) rulemaking hearing for the autoimmune drug Enbrel, moving closer to becoming the first state PDAB to try to implement this ill-conceived mechanism to control drug costs. In... Read More
Networking +
Policy +
Member
Career
Choose